CDC’s Doxycycline Prophylaxis Guidelines Raise Concerns Over STI Prevention Inclusivity
The CDC’s new guidelines on doxycycline post-exposure prophylaxis (doxy PEP) aim to combat rising STIs in the U.S., but significant gaps remain in accessibility for cisgender women and transgender men. This exclusion raises concerns about inclusivity in STI prevention research, emphasizing the need for equitable access to effective health measures for all demographics. As the STI epidemic escalates, comprehensive strategies are crucial to protect sexual health across diverse populations.
Surge in Syphilis Cases Raises Concerns Nationwide
Syphilis cases have surged nationwide, with a nearly 79 percent change from 2018 to 2022. UPMC’s Dr. Ken Ho expressed concern over the rise in congenital syphilis, emphasizing the potential risks for babies. Accessing healthcare and delayed testing may be contributing to the increase. The county health department highlighted the disproportionate impact on men who have sex with men and Black residents. Dr. Ho urged raising awareness, expanding testing availability, and engaging in open conversations about protection and testing to combat the spread of syphilis.